Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-03-04

Clinical Trial Update: Oral Pregabalin as Preemptive Analgesia in Abdominal Hysterectomy [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating oral pregabalin as preemptive analgesia for abdominal hysterectomy has been terminated; results posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pregabalin (Pregabalin)

Snippet

Sponsor: Universidade Federal de Alfenas | Conditions: Pain, Postoperative, Analgesia | Phase 4 | Status: TERMINATED | Results posted: 2021-03-04